These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

317 related articles for article (PubMed ID: 29437298)

  • 1. Moving beyond HbA1c and plasma glucose levels to understand glycemic status in type 2 diabetes mellitus.
    Vijayakumar V; Mavathur R; Aruchunan M; Nandi Krishnamurthy M
    J Diabetes; 2018 Jul; 10(7):609-610. PubMed ID: 29437298
    [No Abstract]   [Full Text] [Related]  

  • 2. Glycemic variability: too often overlooked in type 2 diabetes?
    Johnson EL
    J Fam Pract; 2010 Aug; 59(8):E1-8. PubMed ID: 20714447
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Compliance to treatment and type 2 diabetes: impact on glycemic balance].
    Guillausseau PJ
    Presse Med; 2003 Jan; 32(2):70. PubMed ID: 12653029
    [No Abstract]   [Full Text] [Related]  

  • 4. Comments on the AACE/ACE statement on glycemic control for patients with type 2 diabetes mellitus.
    Eledrisi M
    Endocr Pract; 2010; 16(1):130-1; author reply 131-2. PubMed ID: 20146995
    [No Abstract]   [Full Text] [Related]  

  • 5. Blood glucose patterns in type 2 diabetic patients with optimal fasting plasma glucose but high HbA1c.
    Charoenhirunyingyos W; Nitiyanant W; Thabsang P; Sriussadaporn S; Vannasaeng S
    J Med Assoc Thai; 2011 Mar; 94(3):278-85. PubMed ID: 21560834
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Women with Type 2 Diabetes and Glycemic Control.
    Gosse S
    Medsurg Nurs; 2014; 23(5):317-20, 329. PubMed ID: 26292437
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of Composite Glycemic Indices: A Comparison of the Comprehensive Glucose Pentagon Across Diabetes Types and HbA1c Levels.
    Rama Chandran S; A Vigersky R; Thomas A; Lim LL; Ratnasingam J; Tan A; S L Gardner D
    Diabetes Technol Ther; 2020 Feb; 22(2):103-111. PubMed ID: 31502876
    [No Abstract]   [Full Text] [Related]  

  • 8. Baseline Glycated Hemoglobin Values Predict the Magnitude of Glycemic Improvement in Patients with Type 1 and Type 2 Diabetes: Subgroup Analyses from the DIAMOND Study Program.
    Billings LK; Parkin CG; Price D
    Diabetes Technol Ther; 2018 Aug; 20(8):561-565. PubMed ID: 30044123
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The use of glycated haemoglobin (HbA1
    Mustafa IO; Tanko Y; Yusuf R; Musa SA
    Diabetes Metab Syndr; 2019; 13(5):2967-2972. PubMed ID: 31437811
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Beyond HbA1c.
    Bloomgarden Z
    J Diabetes; 2017 Dec; 9(12):1052-1053. PubMed ID: 28792665
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Relationship between plasma Endothelin-1 and glycemic control in type 2 diabetes mellitus.
    Sánchez SS; Aybar MJ; Velarde MS; Prado MM; Carrizo T
    Horm Metab Res; 2001 Dec; 33(12):748-51. PubMed ID: 11753762
    [No Abstract]   [Full Text] [Related]  

  • 12. Response to intensive therapy steps and to glipizide dose in combination with insulin in type 2 diabetes. VA feasibility study on glycemic control and complications (VA CSDM).
    Abraira C; Henderson WG; Colwell JA; Nuttall FQ; Comstock JP; Emanuele NV; Levin SR; Sawin CT; Silbert CK
    Diabetes Care; 1998 Apr; 21(4):574-9. PubMed ID: 9571345
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Glycemic control in patients with type 2 diabetes mellitus switched from twice-daily immediate-release metformin to a once-daily extended-release formulation.
    Fujioka K; Pans M; Joyal S
    Clin Ther; 2003 Feb; 25(2):515-29. PubMed ID: 12749511
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Correlation of glycosylated serum protein and glycosylated hemoglobin in patients with diabetes mellitus type 2 at various stages of metabolic compensation].
    Plechanow J; Bartosiewicz W; Szczepanik Z
    Pol Arch Med Wewn; 1987 Sep; 78(3):149-53. PubMed ID: 3271294
    [No Abstract]   [Full Text] [Related]  

  • 15. Once Daily Self-Monitoring of Blood Glucose (SMBG) Improves Glycemic Control in Oral Hypoglycemic Agents (OHA)-Treated Diabetes: SMBG-OHA Follow-Up Study.
    Harashima S; Nishimura A; Ikeda K; Wang Y; Liu Y; Inagaki N
    J Diabetes Sci Technol; 2015 Oct; 10(2):378-82. PubMed ID: 26428934
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intensive treatment of hyperglycaemia: ACCORD.
    Klein R
    Lancet; 2010 Aug; 376(9739):391-2. PubMed ID: 20594590
    [No Abstract]   [Full Text] [Related]  

  • 17. Favorable Glycemic Control with Once-Daily Insulin Degludec/Insulin Aspart after Changing from Basal Insulin in Adults with Type 2 Diabetes.
    Jang HN; Yang YS; Lee SO; Oh TJ; Koo BK; Jung HS
    Endocrinol Metab (Seoul); 2019 Dec; 34(4):382-389. PubMed ID: 31884738
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Slow response to loss of glycemic control in type 2 diabetes mellitus.
    Brown JB; Nichols GA
    Am J Manag Care; 2003 Mar; 9(3):213-7. PubMed ID: 12643338
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Beyond HbA1c: Comparing Glycemic Variability and Glycemic Indices in Predicting Hypoglycemia in Type 1 and Type 2 Diabetes.
    Rama Chandran S; Tay WL; Lye WK; Lim LL; Ratnasingam J; Tan ATB; Gardner DSL
    Diabetes Technol Ther; 2018 May; 20(5):353-362. PubMed ID: 29688755
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association of Potentially Modifiable Diabetes Care Factors With Glycemic Control in Patients With Insulin-Treated Type 2 Diabetes.
    Lauffenburger JC; Lewey J; Jan S; Lee J; Ghazinouri R; Choudhry NK
    JAMA Netw Open; 2020 Jan; 3(1):e1919645. PubMed ID: 31968115
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.